Gary J. Grover

Cardioprotective Effect of Diazoxide and Its Interaction With Mitochondrial ATP-Sensitive K⁺Channels

Keith Garlid, Petr Pauček, Vladimir Yarov‐Yarovoy et al. · Circulation Research · 1997 · 1K citations

Medicine, Cardiology, Pharmacology +15

The Thyroid Hormone Receptor-β-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity¹

Susanne U. Trost, Eric A. Swanson, Bernd Gloss et al. · Endocrinology · 2000 · 275 citations

Life Sciences, Endocrinology, Pharmacology +17

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Gary J. Grover, Steven Dzwonczyk, Diane M. McMullen et al. · Journal of Cardiovascular Pharmacology · 1995 · 258 citations

Medicine, Cardiology, Pharmacology +14

Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability

Gary J. Grover, Karin Mellström, Ye Liu et al. · Proceedings of the National Academy of Sciences · 2003 · 223 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Effects of the Thyroid Hormone Receptor Agonist GC-1 on Metabolic Rate and Cholesterol in Rats and Primates: Selective Actions Relative to 3,5,3′-Triiodo-<scp>l</scp>-Thyronine

Gary J. Grover, Donald Egan, Paul G. Sleph et al. · Endocrinology · 2004 · 163 citations · Full text

Life Sciences, Endocrinology, Pharmacology +11